Plaintiff/Cross-Defendant Dr. Joel Linden, Ph.D. brings this motion for a protective order to preclude discovery until Defendant/Cross-Complainant Therinject, LLC identifies its trade secrets.
The request for judicial notice is granted. All objections are overruled.
"In any action alleging the misappropriation of a trade secret under the Uniform Trade Secrets Act (Title 5 (commencing with Section 3426) of Part 1 of Division 4 of the Civil Code), before commencing discovery relating to the trade secret, the party alleging the misappropriation shall identify the trade secret with reasonable particularity subject to any orders that may be appropriate under Section 3426.5 of the Civil Code." CCP §2019.210.
"The letter and spirit of section 2019.210 require the plaintiff, subject to an appropriate protective order, to identify or designate the trade secrets at issue with 'sufficient particularity' to limit the permissible scope of discovery by distinguishing the trade secrets 'from matte
Hearing Date
November 03, 2016
Category
Civil - Unlimited
Type
Misc Complaints - Other
For full print and download access, please subscribe at https://www.trellis.law/.
Plaintiff/Cross-Defendant Dr. Joel Linden, Ph.D. brings this motion for a protective order to preclude discovery until Defendant/Cross-Complainant Therinject, LLC identifies its trade secrets.
The request for judicial notice is granted. All objections are overruled.
"In any action alleging the misappropriation of a trade secret under the Uniform Trade Secrets Act (Title 5 (commencing with Section 3426) of Part 1 of Division 4 of the Civil Code), before commencing discovery relating to the trade secret, the party alleging the misappropriation shall identify the trade secret with reasonable particularity subject to any orders that may be appropriate under Section 3426.5 of the Civil Code." CCP §2019.210.
"The letter and spirit of section 2019.210 require the plaintiff, subject to an appropriate protective order, to identify or designate the trade secrets at issue with 'sufficient particularity' to limit the permissible scope of discovery by distinguishing the trade secrets 'from matte